Projects
LipoMacs: functional Lipidomics to unlock Macrophage-mediated therapy
Five partners from leading Flanders research centers join forces to further elucidate the role of lipid metabolism in macrophages in relevant disease models, with the aim to discover novel therapeutic targets and interventions. Cutting edge lipidomics technologies, including bulk and spatial lipidomics, will be central tools in this work. (project link)
EURLIPIDS, a Virtual Platform for Lipid Research
An international European multi-stakeholder initiative to establish a ”Lipid Valley” - an excellence platform for lipid-based research and technological solutions. This project involves 5 academic partners (KU Leuven, Maastricht University, University Aachen, University Liege, University Hasselt) and 5 Industrial partners (Omics2image, Zentech, Da Vinci Laboratory Solutions, Amsterdam Scientific Instruments B.V., Dutch Screening Group). (project link)
NEURO-TRAFFIC: Integrated platform to validate vesicular trafficking-associated processes in neurodegenerative diseases.
A Flanders Strategic Basic research project (FWO-SBO) focused on deciphering lysosomal transport mechanisms underlaying Alzheimer's and Parkinson's diseases. (project link)
MRTA- Lipids & prostate cancer.
An international multipartner translational project, and first of its kind, to study the links between lipid metabolism, obesity and prostate cancer. (project link)
A mass spectrometry-based lipidomics platform for cancer diagnostics and target identification.
KU Leuven valorisation project to facilitate the setting up and development of Lipometrix. The project further leverages internally developed proprietary lipid-based biomarker signatures and know-how to develop tools for clinical decision-making and therapeutic drug target discovery.
Refining cancer cell death and danger signals for the improvement of immunotherapy
A Belgian multi-partner translational project to improve cancer immunotherapy and facilitate biomarker discovery. The “DECODE consortium” brings together research groups from University of Leuven (KU Leuven), Ghent University (UGent), University of Louvain (UCL) and The Netherlands Cancer Institute (NKI).
